Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,261
-
Total 13F shares
-
3,670,943
-
Share change
-
+13,521
-
Total reported value
-
$52,261,963
-
Price per share
-
$14.23
-
Number of holders
-
63
-
Value change
-
+$42,180
-
Number of buys
-
31
-
Number of sells
-
24
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q2 2022
As of 30 Jun 2022,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,670,943 shares.
The largest 10 holders included
NEEDHAM INVESTMENT MANAGEMENT LLC, MORGAN STANLEY, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, Advisors Asset Management, Inc., LPL Financial LLC, LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, and 180 WEALTH ADVISORS, LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.